Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2019 16:00 ET | Source: Capricor Therapeutics, Inc.

Capricor Therapeutics Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Update

Provides Update on End of Phase Type-B Meeting with FDA Positive Data from the HOPE-2 Clinical Trial Presented at World Muscle Society To Host Conference Call and Webcast Today at 4:30 p.m....
August 06, 2019 16:00 ET | Source: Capricor Therapeutics, Inc.

Capricor Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Positive Results from HOPE-2 Interim Analysis Reported in July To Host Conference Call and Webcast Today at 4:30 p.m. ET LOS ANGELES, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics...
July 30, 2019 08:00 ET | Source: Capricor Therapeutics, Inc.

Capricor Therapeutics to Present Second Quarter 2019 Financial Results and Recent Corporate Update on August 6

LOS ANGELES, July 30, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for...
May 13, 2019 16:00 ET | Source: Capricor Therapeutics, Inc.

Capricor Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

On Track to Report Interim Data from HOPE-2 Clinical Trial in Early Q3 To Host Conference Call and Webcast Today at 4:30 p.m. ET LOS ANGELES, May 13, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics...
March 21, 2019 08:00 ET | Source: Capricor Therapeutics, Inc.

Capricor Therapeutics to Present Fourth Quarter and Full Year 2018 Financial Results and Recent Corporate Update on March 28

LOS ANGELES, March 21, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for...
November 13, 2018 16:01 ET | Source: Capricor Therapeutics, Inc.

Capricor Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update

To Host Conference Call and Webcast Today at 4:30 p.m. ET LOS ANGELES, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the...
October 22, 2018 07:00 ET | Source: Capricor Therapeutics, Inc.

Capricor Therapeutics to Participate in Upcoming Conferences

Presentations to Focus on Company’s Exosome-based and Duchenne Muscular Dystrophy Therapies LOS ANGELES, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Linda Marbán, Ph.D, CEO of Capricor Therapeutics, Inc....
October 03, 2018 07:00 ET | Source: Capricor Therapeutics, Inc.

Capricor Therapeutics to Present at 2018 Cell & Gene Meeting on the Mesa

LA JOLLA, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR) will provide a presentation at the 2018 Cell & Gene Meeting on the Mesa today on its cell therapy,...
August 21, 2018 07:00 ET | Source: Capricor Therapeutics, Inc.

Capricor Therapeutics Presents Results of Studies of CAP-2003 at Gordon Research Conference on Extracellular Vesicles

LOS ANGELES, Aug. 21, 2018 (GLOBE NEWSWIRE) -- At the Gordon Research Conference on Extracellular Vesicles in Newry, Maine, Capricor Therapeutics (NASDAQ: CAPR) presented research findings on the...
July 17, 2018 07:00 ET | Source: Capricor Therapeutics, Inc.

Capricor and USAISR Announce Collaboration to Investigate Exosome Platform to Treat Injured Troops

LOS ANGELES, July 17, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR) today announced it has entered into an agreement with the U.S. Army Institute of Surgical Research (USAISR) to...